Skip to main content
  • Corporate Profile
    • About Us
      • Company Overview
      • Leadership
      • Partnering
      • Contact Us
    • Our Science
      • Technology Platform
      • Publications
    • Our Programs
      • Pipeline
      • PSMA TRACTr (JANX007)
      • EGFR TRACTr (JANX008)
      • TROP2 TRACTr
      • PD-L1 x CD28 TRACIr (JANX009)
      • Clinical Trials
    • Join Us
      • Job Openings
      • Our Culture
      • Diversity Program
    • Investor & Media
      • Corporate Profile
      • Press Releases
      • Events & Presentations
      • Stock Info
        • Stock Quote
        • Analyst Coverage
      • SEC Filings
      • Governance
        • Governance Documents
        • Committee Composition
        • Executive Management
        • Board of Directors
      • Resources
        • Investor FAQs
        • Information Request Form
        • Investor Email Alerts
        • Investor Contacts
Placeholder Company

Investor FAQs

  • Corporate Profile
    • About Us
      • Company Overview
      • Leadership
      • Partnering
      • Contact Us
    • Our Science
      • Technology Platform
      • Publications
    • Our Programs
      • Pipeline
      • PSMA TRACTr (JANX007)
      • EGFR TRACTr (JANX008)
      • TROP2 TRACTr
      • PD-L1 x CD28 TRACIr (JANX009)
      • Clinical Trials
    • Join Us
      • Job Openings
      • Our Culture
      • Diversity Program
    • Investor & Media
      • Corporate Profile
      • Press Releases
      • Events & Presentations
      • Stock Info
        • Stock Quote
        • Analyst Coverage
      • SEC Filings
      • Governance
        • Governance Documents
        • Committee Composition
        • Executive Management
        • Board of Directors
      • Resources
        • Investor FAQs
        • Information Request Form
        • Investor Email Alerts
        • Investor Contacts

Contact Us

Janux Therapeutics
10955 Vista Sorrento Parkway,
Suite 200
San Diego, CA 92130

Send Email

Quick Links

SEC Filings

Investor FAQs

Information Request Form

Investor Email Alerts

To opt-in for investor email alerts, please enter your email address in the field below and select at least one alert option. After submitting your request, you will receive an activation email to the requested email address. You must click the activation link in order to complete your subscription. You can sign up for additional alert options at any time.

At Janux Therapeutics, we promise to treat your data with respect and will not share your information with any third party. You can unsubscribe to any of the investor alerts you are subscribed to by visiting the ‘unsubscribe’ section below. If you experience any issues with this process, please contact us for further assistance.

By providing your email address below, you are providing consent to Janux Therapeutics to send you the requested Investor Email Alert updates.

* Required

*
Investor Alert Options
*





Unsubscribe

Email Alert Sign Up Confirmation

  • About Us
  • Company Overview
  • Leadership
  • Partnering
  • Contact Us
  • Our Science
  • Technology Platform
  • Publications
  • OUR PROGRAMS
  • Pipeline
  • PSMA TRACTr (JANX007)
  • EGFR TRACTr (JANX008)
  • TROP2 TRACTr
  • PD-L1 x CD28 TRACIr (JANX009)
  • Clinical Trials
  • Join Us
  • Job Openings
  • Our Culture
  • Diversity Program
  • Investors & Media
  • Press Releases
  • Events & Presentations
  • Stock Information
  • SEC Filings
  • Governance
  • IR Resources
  • Privacy Policy
  • Terms of Use
Placeholder Company
© Q4 Inc. - All rights reserved
Powered By Q4 Inc. 5.104.0.1 (opens in new window)